cancer/testis antigen
Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E
12
Cancer testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma
12
Cancer testis antigen and immunotherapy
9
Molecular Expression Analysis of Restrictive Receptor for Interleukin 13, a Brain Tumor-associated Cancer/Testis Antigen
10
Original Article Expression status and prognostic value of cancer/testis antigen OY-TES-1 in glioma
10
Prevalence of plasma autoantibody against cancer testis antigen NY ESO 1 in HTLV 1 infected individuals with different clinical status
6
Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy
17
Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer
16
Original Article Down-regulation of cancer/testis antigen OY-TES-1 attenuates malignant behaviors of hepatocellular carcinoma cells in vitro
12
Original Article Cancer testis antigen OY-TES-1 expression and serum immunogenicity in colorectal cancer: its relationship to clinicopathological parameters
11
Down-regulation of the cancer/testis antigen 45 (CT45) is associated with altered tumor cell morphology, adhesion and migration
12
CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers
7
Review Article Colon adenocarcinoma prognosis by BORIS a cancer-testis antigen
6
Cancer/Testis Antigens and Colorectal Cancer
10
Complete Remission Following Decitabine/Dendritic Cell Vaccine for Relapsed Neuroblastoma
8
Cancer/testis antigens (CTAs) expression in resected lung cancer
9
MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells
18
Association of serum follistatin levels with histological types and progression of tumor in human lung cancer
8
Inducible expression of cancer-testis antigens in human prostate cancer
16
Diagnostic value of serum cancer antigen 125 in ovarian cancer patients
7